Scope International AG is proud to announce that its subsidiary in the United States, Scope International USA, Inc., was successfully inspected by the US Food and Drug Administration in June 2019.
The outcome of this FDA inspection is the most recent example of the high-quality results produced by the SCOPE team. Our clients can focus on the science of product development, while trusting SCOPE to follow the regulations and remain inspection ready at all times. Since the foundation of SCOPE in the year 2000, the company has successfully completed multiple FDA, EMA, and BfArM company inspections, along with countless inspections of sites that were a part of SCOPE clinical trials.
NewsScope International announces successful FDA inspection
We are excited to announce that SCOPE will be participating in the 9th annual Outsourcing in Clinical Trials Europe 2019 in Milan, Italy. Our Head of Biostatistics will give a talk titled „Efficiency through Quality by Design – How QbD will help in defining your outsourcing strategy”.
Scope International AG is pleased to announce the appointment of Björn Boße as new head of biostatistics. Together with Dr. Klaus Junge as Senior Biostatisticial Advisor Scope International offers an exceptional expertise in biostatistics. Björn and Klaus have both more than 20 years of experience in the pharmaceutical industry as e.g. Director Biostatistics and Executive Director European Biostatistics, respectively. Due to their outstanding expert knowledge in many indications, they will contribute to expanding several business areas of SCOPE.
NewsSpotlight on our Biostatistic experts and strategic consulting team
Scope International AG is pleased to announce the appointment of Adam Braithwaite as the key contact for Business Development in the U.S. Adam will join the SCOPE BD team as part of its North American subsidiary, Scope International USA, based in Pittsburgh, PA. In his new position, he will support our clients for their ongoing needs and will support the development of future products together with our customers.
NewsAdam Braithwaite appointed to the Business Development Team for the U.S.
Scope International Italy is proud to announce the partnership with Assolombarda Confindustria Milano, Monza e Brianza, Lodi, the largest territorial entrepreneurial association in Italy. In particular, SCOPE has joined the pharmaceutical companies group and the “Filiera” Life Sciences. The Filiera provides a framework in which all the companies associated with Assolombarda that are working in the Life Sciences industry in Lombardy have the opportunity to interact with each other.
NewsSCOPE enters partnership with Assolombarda Confindustria
Scope International AG has announced the appointment of Andrew Bradshaw as the new UK Managing Director for its subsidiary, based in Manchester, UK. Guiding a highly motivated and qualified team, Andrew will be responsible for the strategic development of Scope International (UK) Ltd.
Scope International AG is pleased to announce the appointment of Amy O’Sullivan as the new Managing Director of its North American subsidiary, based in Pittsburgh, Pennsylvania. Guiding SCOPE’s business in our fastest growing market, Amy will take over an essential part of our strategic development and leading a growing team.
NewsNew Managing Director for North American Operations